1. bookVolumen 60 (2010): Edición 4 (December 2010)
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
ISSN
1330-0075
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés
Acceso abierto

Silymarin-solid dispersions: Characterization and influence of preparation methods on dissolution

Publicado en línea: 17 Dec 2010
Volumen & Edición: Volumen 60 (2010) - Edición 4 (December 2010)
Páginas: 427 - 443
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
ISSN
1330-0075
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés

S. Ahmad and N. Dixit, Silymarin: a review of pharmacological aspects and bioavailability enhancement approach, Ind. J. Pharm. 39 (2007) 172-179; DOI: 10.4103/0253-7613.36534.10.4103/0253-7613.36534Search in Google Scholar

S. Abrol, T. Aman and K. O. Parkash, Comparative study of different silymarin formulations: formulation, characterization and in vitro/in vivo evaluation, Curr. Drug Deliv. 2 (2005) 45-51; DOI: 1567-2018/05 $50.00+.00.Search in Google Scholar

P. D. Nakhat, R. A. Naidu, I. B. Babla, S. Khan and P. G. Yeole, Design and evaluation of silymarin-HP-β-CD solid dispersion tablets, J. Pharm. Sci. 69 (2007) 287-289; DOI: 10.4103/0250-474X.33160.10.4103/0250-474X.33160Search in Google Scholar

J. H. Hu and F. Q. Li, Improvement of the dissolution rate of silymarin by means of solid dispersions, Chem. Pharm. Bull. 52 (2004) 972-973; DOI: 10.1248/cpb.52.972.10.1248/cpb.52.972Search in Google Scholar

S. W. Jong, T. S. Kim, J. H. Park, and S. C. Chi, Formulation and biopharmaceutical evaluation of silymarin using SMEDDS, Arch. Pharm. Res. 30 (2007) 82-89; DOI: 10.1007/BF02977782.10.1007/BF02977782Search in Google Scholar

W. Wachter and H. Zeskae, Flavanolignan Preparation and their Use for Preparation of Pharmaceuticals, U.S. Pat. 5,906,991, 25 May 1999.Search in Google Scholar

D. Voinovich, B. Perrisuiti and L. Maggaroto, Solid state mechanochemical simultaneous activation of the constituents of the Silybum marianum phytochemical complex with crosslinked polymers, J. Pharm. Sci. 3 (2008) 1-14; DOI: 10.1002/jps.21417.10.1002/jps.21417Search in Google Scholar

J. B. Dressman and L. Christian, Improving drug solubility for oral delivery using solid dispersions, Eur. J. Pharm. BioPharm. 50 (2000) 47-60; DOI: 10.1016/S0939-6411(00)00076-X.10.1016/S0939-6411(00)00076-XSearch in Google Scholar

Y. Rane, R. Mashru, M. Sankalia and J. Sankalia, Effect of hydrophilic swellable polymers on dissolution enhancement of carbamazepine solid dispersions studied using response surface methodology, AAPS Pharm. Sci. Tech. 8 (2007) Article 27; DOI: 10.1208/pt0802027.10.1208/pt0802027Search in Google Scholar

A. Avani and M. Renuka, Formulation development of taste-masked rapidly dissolving films of cetirizine hydrochloride, Pharm. Tech. 33 (2009) 48-56.Search in Google Scholar

S. J. Hwang, D. H. Won, M. S. Kim, S. Lee and J. S. Park, Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process, Int. J. Pharm. 301 (2005) 199-208; DOI: 10.1016/j.ijpharm.2005.05.017.10.1016/j.ijpharm.2005.05.017Search in Google Scholar

United States Pharmacopoeia 24/National Formulary 19, USP Convention, Rockville 2000, p. 2235.Search in Google Scholar

P. Costa and L. J. Manuel Sousa, Modelling and comparison of dissolution profiles, Eur. J. Pharm. Sci. 13 (2001) 123-133; DOI: 10.1016/S0928-0987(01)00095-1.10.1016/S0928-0987(01)00095-1Search in Google Scholar

J. W. Moore and H. H. Flanner, Mathematical comparison of dissolution profiles, Pharm. Tech. 20 (1996) 64-74.Search in Google Scholar

R. P. Patel and M. M. Patel, Solid-state characterization and dissolution properties of lovastatin hydroxypropyl-beta-cyclodextrin inclusion complex, Pharm. Tech. 2 (2007) 72-81.Search in Google Scholar

S. Baboota, M. Dhalival and K. Kohli, Physicochemical characterization, in vitro dissolution behaviour, and pharmacodynamic studies of rofecoxib-cyclodextrin inclusion compounds: preparation and properties of rofecoxib hydroxypropyl β-cyclodextrin inclusion complex: a technical note, AAPS Pharm. Sci. Tech. 6 (2005) 83-90; DOI: 10.1208/pt060114.10.1208/pt060114275041516353967Search in Google Scholar

M. A. Khan and A. A. Karnachi, Box-Behnken design for the optimization of formulation variables of indomethacin co-precipitates with polymer mixtures, Int. J. Pharm. 131 (1996) 9-17; DOI: 10.1016/0378-5173(95)04216-4.10.1016/0378-5173(95)04216-4Search in Google Scholar

S. Torrado, P. D. Torre and S. Torrado, Preparation, dissolution and characterization of pranziquantel solid dispersions, Chem. Pharm. Bull. 47 (1999) 1629-1633; DOI: 99A1042280.10.1248/cpb.47.1629Search in Google Scholar

S. R. Vikram, M. R. Shelake, S. S. Shetty, A. B. Chavan-Patil, Y. V. Pore and S. G. Late, Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique, J. Pharm. Pharm. Sci. 60 (2008) 1121-1129; DOI: 10.1211/jpp.60.9.0002.10.1211/jpp.60.9.0002Search in Google Scholar

K. Okimoto, M. Miyake, R. Ibuki, M. Yasumura, N. Ohnishi and T. Nakai, Dissolution mechanism and rate of solid dispersion particles of nilvadipine with hydroxypropylmethylcellulose, Int. J. Pharm. 159 (1997) 85-93; DOI: 10.1016/S0378-5173(97)00274-3.10.1016/S0378-5173(97)00274-3Search in Google Scholar

M. S. Nagarsenker and M. S. Joshi, Celecoxib cyclodextrin systems: characterization and evaluation of in vitro and in vivo advantage, Drug Dev. Ind. Pharm. 31 (2005) 169-178; DOI: 10.1081/DDC-200047795.10.1081/DDC-20004779515773284Search in Google Scholar

Artículos recomendados de Trend MD

Planifique su conferencia remota con Sciendo